BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-5.4%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-5.4%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 17.15% |
| 2024 | -45.71% |
| 2023 | -60.78% |
| 2022 | -118.43% |
| 2021 | -83.95% |
| 2020 | 22.62% |
| 2019 | -25.76% |
| 2018 | -54.65% |
| 2017 | -46.55% |
| 2016 | -17.00% |